How immune checkpoint inhibitors induce diabetes
When Ana Luisa Perdigoto, MD, and PhD first joined Dr. Kevan Herold's lab to study type 1 diabetes, the patient was just beginning to develop immune checkpoint inhibitor-induced diabetes. As…
When Ana Luisa Perdigoto, MD, and PhD first joined Dr. Kevan Herold's lab to study type 1 diabetes, the patient was just beginning to develop immune checkpoint inhibitor-induced diabetes. As…
Our easy-to-read fact sheets provide clinicians with reliable information to share with patients and their caregivers. The main risk factor for type 2 diabetes is being overweight or obese, so…